Translating evidence into
clinical practice:

It is with great pleasure that we invite you to attend this 60-minute webinar as part of the IMPaCT webinar series.

In this webinar, we will highlight recent advances in the mCRPC treatment landscape, with a focus on PARPi + ARPi combination therapies. We will identify patient populations most likely to benefit, based on clinical data and patient profiling. In addition, the role of timely HRR testing in optimising informed treatment decisions will be addressed. Through case-based discussions, we will demonstrate the clinical application of talazoparib + enzalutamide, emphasising efficacy, safety, and treatment management. We will also take questions from the audience during the live Q&A session.